findmyKOL
Clinical trialNCT04333459CompletedPhase 2Interventional

Safety/Immunogenicity Hantaan Virus DNA Vaccine and Puumala Virus DNA Vaccine, For Prevention of HFRS

SponsorU.S. Army Medical Research and Development CommandEnrollment132Hantaan Virus NephropathyPuumala Virus Nephropathy
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Trevor Wellington, MD

    Walter Reed Army Institute of Research (WRAIR)

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Clinical Trials Center, Walter Reed Army Institute of Reserach

    Silver Spring, Maryland, United States

  • Department of Clinical Trials, Wrair

    Silver Spring, Maryland, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Aug 2021
Primary completion
15 Oct 2024
Completion
15 Oct 2024
Last update posted
19 May 2026
Registered enrollment
132
Registry id
NCT04333459

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.